Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial.
Myosin filament structure in vertebrate smooth muscle.
Symptomatic developmental venous anomalies.
Youth Sports
Pulmonary complications of tumor necrosis factor-targeted therapy.
See All 6 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pulmonary complications of tumor necrosis factor-targeted therapy.
Thavarajah K, Wu P, Rhew EJ, Yeldandi AK, Kamp DW. Pulmonary complications of tumor necrosis factor-targeted therapy. Respir Med. 2009 May; 103(5):661-9.
View in:
PubMed
subject areas
Adalimumab
Adult
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Anti-Inflammatory Agents
Autoimmune Diseases
Communicable Diseases
Etanercept
Female
Humans
Immunoglobulin G
Inflammation
Infliximab
Lung Diseases
Male
Middle Aged
Radiography
Receptors, Tumor Necrosis Factor
authors with profiles
Peggy W Wu MD